Cargando…

Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study

BACKGROUND: Mild cognitive impairment (MCI) is an intermediate stage between normal aging and dementia. Studies on MCI progression are important for Alzheimer’s disease (AD) prevention. 18F fluoro-deoxy-glucose positron emission tomography (FDG-PET) has been proven to be a powerful tool for measurin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Lirong, Li, Yongchao, Zhao, Yu, Hu, Tao, Zhang, Zhe, Yao, Zhijun, Hu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171825/ https://www.ncbi.nlm.nih.gov/pubmed/32316912 http://dx.doi.org/10.1186/s12883-020-01728-x

Ejemplares similares

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI
por: Carlson, Mackenzie L., et al.
Publicado: (2020)

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
por: Caminiti, Silvia Paola, et al.
Publicado: (2018)

Mild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid(®) Treatment on Cognition and (18)F-FDG PET Scans
por: Manzano Palomo, Maria Sagrario, et al.
Publicado: (2019)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers()()
por: Da, Xiao, et al.
Publicado: (2013)

A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers
por: Yao, Zhijun, et al.
Publicado: (2015)

Aberrant Hippocampal Subregion Networks Associated with the Classifications of aMCI Subjects: A Longitudinal Resting-State Study
por: Bai, Feng, et al.
Publicado: (2011)

Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers
por: Zhang, Daoqiang, et al.
Publicado: (2012)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Brain Connectivity Based Prediction of Alzheimer’s Disease in Patients With Mild Cognitive Impairment Based on Multi-Modal Images
por: Zheng, Weihao, et al.
Publicado: (2019)

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
por: Varatharajah, Yogatheesan, et al.
Publicado: (2019)

Risk Factors for Mild Cognitive Impairment (MCI)
por: Loftus, Andrea Mary
Publicado: (2017)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

Prediction of long-term memory scores in MCI based on resting-state fMRI
por: Meskaldji, Djalel-Eddine, et al.
Publicado: (2016)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR
por: Goubran, Maged, et al.
Publicado: (2015)

Modifiable Lifestyle Factors Associated with Cognitive Recovery from MCI: A 12-Year Longitudinal Study
por: Li, Bingyu
Publicado: (2021)

Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2021)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
por: Sha, Wei, et al.
Publicado: (2013)

EEG Patterns in Mild Cognitive Impairment (MCI) Patients
por: Baker, Mary, et al.
Publicado: (2008)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats
por: Zhou, Qian, et al.
Publicado: (2022)

Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning
por: Booth, Samuel, et al.
Publicado: (2022)

Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI
por: Lauretani, Fulvio, et al.
Publicado: (2020)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2020)

FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
por: Cabrera-Martín, María Nieves, et al.
Publicado: (2023)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Neuroanatomical and Neuropsychological Markers of Amnestic MCI: A Three-Year Longitudinal Study in Individuals Unaware of Cognitive Decline
por: Goerlich, Katharina S., et al.
Publicado: (2017)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Association of Anxiety Awareness with Risk Factors of Cognitive Decline in MCI
por: Gigi, Ariela, et al.
Publicado: (2021)

Electrophysiological Studies of Cognitive Reappraisal Success and Failure in aMCI
por: Xiao, Shasha, et al.
Publicado: (2021)

The outcomes of the computerized training of cognitive functions in patients with MCI in epilepsy
por: Blazhina, I., et al.
Publicado: (2022)

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
por: Smith, Ruben, et al.
Publicado: (2016)

Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o6v8b4dklchefgfelp81o17lde